Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/25/06 | 2-E | Report of sales of securities pursuant to Rule 609 under Regulation E. |
|
1 | |
| 09/20/06 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
36 | |
| 09/13/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/10/06 | 2-E | Report of sales of securities pursuant to Rule 609 under Regulation E. |
|
1 | |
| 08/10/06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
15 | |
| 08/08/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/08/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/08/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/07/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/13/06 | 3 | Initial statement of beneficial ownership of securities |
|
2 |
